Neurophage Pharmaceuticals
HomeAbout UsOur ScienceNewsCareersContact Us

About Us

. . . . . . . . . . . . . . . . . . . . . .

Management

. . . . . . . . . . . . . . . . . . . . . .

Board of Directors

. . . . . . . . . . . . . . . . . . . . . .

Scientific Advisory Board

. . . . . . . . . . . . . . . . . . . . . .

Current Investors

. . . . . . . . . . . . . . . . . . . . . .

Partners

. . . . . . . . . . . . . . . . . . . . . .

 

 

Jonathan Solomon, MBA
President and Chief Executive Officer
-> read bio

Hampus Hillerstrom, MBA
Executive VP and Chief Financial Officer
-> read bio

Richard Fisher, PhD
Chief Scientific Officer
-> read bio

Kimberley S. Gannon, PhD
SVP Preclinical Research and Development
-> read bio

Roxanne Bales, MA
VP Regulatory and Compliance
-> read bio

Jason Wright, PhD
VP Manufacturing
-> read bio

Michael Grundman, MD, MPH
Clinical Development Leader
-> read bio